Status:
COMPLETED
Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
Lead Sponsor:
University of Ulm
Conditions:
Prematurity of Fetus
Patent Ductus Arteriosus
Eligibility:
All Genders
Up to 34 years
Brief Summary
The purpose of this study is to examine the influence medical or surgical treatment for patent ductus arteriosus in preterm infants on cerebral and renal tissue oxygenation and on cardiac output.
Detailed Description
In this observational trial the investigators want to examine whether clinical or echocardiographic parameters of patent ductus arteriosus are related to * cerebral tissue oxygen saturation, total he...
Eligibility Criteria
Inclusion
- Newborn infant below 34 weeks postmenstrual age at the time of birth
- Patent ductus arteriosus with signs of hemodynamic relevance (as judged by the attending neonatologist)
- parental informed consent
Exclusion
- Patent ductus arteriosus as part of malformation syndrome
- Additional major cardiovascular malformations
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01428180
Start Date
April 1 2011
End Date
March 1 2016
Last Update
April 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center
Ulm, Baden-Wurttemberg, Germany, 89075